Target Product Profile of a Molecular Drug-Susceptibility Test for Use in Microscopy Centers | Zendy

Claudia M. Denkinger | Zendy; David L. Dolinger | Zendy; Marco Schito | Zendy; William A. Wells | Zendy; Frank Cobelens | Zendy; Madhukar Pai | Zendy; Matteo Zignol | Zendy; Daniela María Cirillo | Zendy; David Alland | Zendy; Martina Casenghi | Zendy; Jim Gallarda | Zendy; Catharina Boehme | Zendy; Mark D. Perkins | Zendy

AI Assistant Blog Pricing

Open Access

Target Product Profile of a Molecular Drug-Susceptibility Test for Use in Microscopy Centers

Author(s) -

Claudia M. Denkinger,

David L. Dolinger,

Marco Schito,

William A. Wells,

Frank Cobelens,

Madhukar Pai,

Matteo Zignol,

Daniela María Cirillo,

David Alland,

Martina Casenghi,

Jim Gallarda,

Catharina Boehme,

Mark D. Perkins

Publication year - 2015

Publication title -

the journal of infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.69

H-Index - 252

eISSN - 1537-6613

pISSN - 0022-1899

DOI - 10.1093/infdis/jiu682

Subject(s) - test (biology) , tuberculosis , stakeholder , medicine , product (mathematics) , drug resistance , turnaround time , computer science , risk analysis (engineering) , biology , pathology , genetics , operating system , public relations , mathematics , paleontology , political science , geometry

Current phenotypic testing for drug resistance in patients with tuberculosis is inadequate primarily with respect to turnaround time. Molecular tests hold the promise of an improved time to diagnosis.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Our institutional solutions Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Discover

Explore

Home ZAIA Blog